Cargando…
Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains
BACKGROUND: Different strains of the genus Bacillus are versatile candidates for the industrial production and secretion of heterologous proteins. They can be cultivated quite easily, show high growth rates and are usually non-pathogenic and free of endo- and exotoxins. They have the ability to secr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259949/ https://www.ncbi.nlm.nih.gov/pubmed/28115011 http://dx.doi.org/10.1186/s12934-017-0625-9 |
_version_ | 1782499309853343744 |
---|---|
author | Lakowitz, Antonia Krull, Rainer Biedendieck, Rebekka |
author_facet | Lakowitz, Antonia Krull, Rainer Biedendieck, Rebekka |
author_sort | Lakowitz, Antonia |
collection | PubMed |
description | BACKGROUND: Different strains of the genus Bacillus are versatile candidates for the industrial production and secretion of heterologous proteins. They can be cultivated quite easily, show high growth rates and are usually non-pathogenic and free of endo- and exotoxins. They have the ability to secrete proteins with high efficiency into the growth medium, which allows cost-effective downstream purification processing. Some of the most interesting and challenging heterologous proteins are recombinant antibodies and antibody fragments. They are important and suitable tools in medical research for analytics, diagnostics and therapy. The smallest conventional antibody fragment with high-affinity binding to an antigen is the single-chain fragment variable (scFv). Here, different strains of the genus Bacillus were investigated using diverse cultivation systems for their suitability to produce and secret a recombinant scFv. RESULTS: Extracellular production of lysozyme-specific scFv D1.3 was realized by constructing a plasmid with a xylose-inducible promoter optimized for Bacillus megaterium and the D1.3scFv gene fused to the coding sequence of the LipA signal peptide from B. megaterium. Functional scFv was successfully secreted with B. megaterium MS941, Bacillus licheniformis MW3 and the three Bacillus subtilis strains 168, DB431 and WB800N differing in the number of produced proteases. Starting with shake flasks (150 mL), the bioprocess was scaled down to microtiter plates (1250 µL) as well as scaled up to laboratory-scale bioreactors (2 L). The highest extracellular concentration of D1.3 scFv (130 mg L(−1)) and highest space–time-yield (8 mg L(−1) h(−1)) were accomplished with B. subtilis WB800N, a strain deficient in eight proteases. These results were reproduced by the production and secretion of a recombinant penicillin G acylase (Pac). CONCLUSIONS: The genus Bacillus provides high potential microbial host systems for the secretion of challenging heterologous proteins like antibody fragments and large proteins at high titers. In this study, the highest extracellular concentration and space–time-yield of a recombinant antibody fragment for a Gram-positive bacterium so far was achieved. The successful interspecies use of the here-designed plasmid originally optimized for B. megaterium was demonstrated by two examples, an antibody fragment and a penicillin G acylase in up to five different Bacillus strains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0625-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5259949 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52599492017-01-26 Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains Lakowitz, Antonia Krull, Rainer Biedendieck, Rebekka Microb Cell Fact Research BACKGROUND: Different strains of the genus Bacillus are versatile candidates for the industrial production and secretion of heterologous proteins. They can be cultivated quite easily, show high growth rates and are usually non-pathogenic and free of endo- and exotoxins. They have the ability to secrete proteins with high efficiency into the growth medium, which allows cost-effective downstream purification processing. Some of the most interesting and challenging heterologous proteins are recombinant antibodies and antibody fragments. They are important and suitable tools in medical research for analytics, diagnostics and therapy. The smallest conventional antibody fragment with high-affinity binding to an antigen is the single-chain fragment variable (scFv). Here, different strains of the genus Bacillus were investigated using diverse cultivation systems for their suitability to produce and secret a recombinant scFv. RESULTS: Extracellular production of lysozyme-specific scFv D1.3 was realized by constructing a plasmid with a xylose-inducible promoter optimized for Bacillus megaterium and the D1.3scFv gene fused to the coding sequence of the LipA signal peptide from B. megaterium. Functional scFv was successfully secreted with B. megaterium MS941, Bacillus licheniformis MW3 and the three Bacillus subtilis strains 168, DB431 and WB800N differing in the number of produced proteases. Starting with shake flasks (150 mL), the bioprocess was scaled down to microtiter plates (1250 µL) as well as scaled up to laboratory-scale bioreactors (2 L). The highest extracellular concentration of D1.3 scFv (130 mg L(−1)) and highest space–time-yield (8 mg L(−1) h(−1)) were accomplished with B. subtilis WB800N, a strain deficient in eight proteases. These results were reproduced by the production and secretion of a recombinant penicillin G acylase (Pac). CONCLUSIONS: The genus Bacillus provides high potential microbial host systems for the secretion of challenging heterologous proteins like antibody fragments and large proteins at high titers. In this study, the highest extracellular concentration and space–time-yield of a recombinant antibody fragment for a Gram-positive bacterium so far was achieved. The successful interspecies use of the here-designed plasmid originally optimized for B. megaterium was demonstrated by two examples, an antibody fragment and a penicillin G acylase in up to five different Bacillus strains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-017-0625-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-23 /pmc/articles/PMC5259949/ /pubmed/28115011 http://dx.doi.org/10.1186/s12934-017-0625-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lakowitz, Antonia Krull, Rainer Biedendieck, Rebekka Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains |
title | Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains |
title_full | Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains |
title_fullStr | Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains |
title_full_unstemmed | Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains |
title_short | Recombinant production of the antibody fragment D1.3 scFv with different Bacillus strains |
title_sort | recombinant production of the antibody fragment d1.3 scfv with different bacillus strains |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259949/ https://www.ncbi.nlm.nih.gov/pubmed/28115011 http://dx.doi.org/10.1186/s12934-017-0625-9 |
work_keys_str_mv | AT lakowitzantonia recombinantproductionoftheantibodyfragmentd13scfvwithdifferentbacillusstrains AT krullrainer recombinantproductionoftheantibodyfragmentd13scfvwithdifferentbacillusstrains AT biedendieckrebekka recombinantproductionoftheantibodyfragmentd13scfvwithdifferentbacillusstrains |